Partnership forged for project targeting pancreatic cancer

08:33 EDT 9 Aug 2017 | EPM Magazine

UK-based independent drug discovery expert and research partner, Sygnature Discovery, and University College London (UCL) School of Pharmacy have formed a partnership for a £1 million pancreatic cancer research project.

Original Article: Partnership forged for project targeting pancreatic cancer


More From BioPortfolio on "Partnership forged for project targeting pancreatic cancer"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...